Requirement for safety monitoring for approved multiple sclerosis therapies: an overview

During the last two decades, treatment options for patients with multiple sclerosis (MS) have broadened tremendously. All agents that are currently approved for clinical use have potential side effects, and a careful risk–benefit evaluation is part of a decision algorithm to identify the optimal tre...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Rommer, P S, Zettl, U K, Kieseier, B, Hartung, H-P, Menge, T, Frohman, E, Greenberg, B M, Hemmer, B, Stüve, O
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2014
Matèries:
Review Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3927900/
https://ncbi.nlm.nih.gov/pubmed/24102425
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.12206
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars